Clinical Trial Update: Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a radiolabeled monoclonal antibody for advanced colorectal cancer has completed; sponsored by Memorial Sloan Kettering Cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Radiolabeled monoclonal antibody

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED